November 28, 2016 - By olga
In a analysts report shared with investors today, FBR Capital downgraded shares of MetLife (NYSE:MET) to a Market Perform rating from a Outperform rating.
Out of 12 analysts covering MetLife (NYSE:MET), 7 rate it a “Buy”, 0 “Sell”, while 5 “Hold”. This means 58% are positive. $65.0 is the highest target while $46 is the lowest. The $55 average target is 0.38% above today’s ($54.79) stock price. MetLife has been the topic of 16 analyst reports since July 31, 2015 according to StockzIntelligence Inc. The stock has “Buy” rating given by Deutsche Bank on Friday, July 31. On Thursday, January 14 the stock rating was upgraded by Macquarie Research to “Outperform”. Sandler O’Neill upgraded the stock to “Buy” rating in Monday, June 27 report. RBC Capital Markets maintained Metlife Inc (NYSE:MET) rating on Tuesday, January 19. RBC Capital Markets has “Outperform” rating and $65.0 price target. The stock of Metlife Inc (NYSE:MET) has “Strong Buy” rating given on Friday, January 22 by Raymond James. The stock of Metlife Inc (NYSE:MET) has “Neutral” rating given on Friday, October 7 by Credit Suisse. FBR Capital maintained it with “Outperform” rating and $54 target price in Monday, August 29 report. The stock of Metlife Inc (NYSE:MET) earned “Hold” rating by Deutsche Bank on Wednesday, July 13. The rating was reinitiated by Wells Fargo on Friday, September 23 with “Outperform”. Citigroup downgraded the stock to “Neutral” rating in Tuesday, January 5 report.
About 4.11M shares traded hands. Metlife Inc (NYSE:MET) has risen 19.92% since April 25, 2016 and is uptrending. It has outperformed by 13.90% the S&P500.
Analysts await Metlife Inc (NYSE:MET) to report earnings on February, 1. They expect $1.35 earnings per share, up 9.76% or $0.12 from last year’s $1.23 per share. MET’s profit will be $1.49B for 10.15 P/E if the $1.35 EPS becomes a reality. After $1.28 actual earnings per share reported by Metlife Inc for the previous quarter, Wall Street now forecasts 5.47% EPS growth.
Insitutional Activity: The institutional sentiment decreased to 0.93 in Q2 2016. Its down 0.11, from 1.04 in 2016Q1. The ratio turned negative, as 55 funds sold all Metlife Inc shares owned while 343 reduced positions. 81 funds bought stakes while 334 increased positions. They now own 797.11 million shares or 0.92% less from 804.49 million shares in 2016Q1.
Nbt Bancorp N A reported 13,809 shares or 0.1% of all its holdings. Stellar Cap Mngmt Ltd Liability Corporation holds 62,111 shares or 2.7% of its portfolio. First Citizens Savings Bank & Company has invested 0.04% of its portfolio in Metlife Inc (NYSE:MET). Mackenzie Fincl has invested 0.03% of its portfolio in Metlife Inc (NYSE:MET). Calamos Wealth Ltd has 0.67% invested in the company for 95,341 shares. Oakbrook Invs Ltd owns 78,455 shares or 0.17% of their US portfolio. Pitcairn last reported 40,211 shares in the company. Levin Capital Strategies Lp last reported 567,505 shares in the company. Systematic Mgmt Limited Partnership last reported 0.26% of its portfolio in the stock. Aviva Public Ltd Com last reported 0.16% of its portfolio in the stock. Axa reported 282,676 shares or 0.05% of all its holdings. Aperio Group Limited Liability Com owns 415,417 shares or 0.13% of their US portfolio. At Fincl Bank last reported 0.09% of its portfolio in the stock. Private Advisor Limited Liability last reported 0.08% of its portfolio in the stock. Poplar Forest Lc accumulated 1.06M shares or 3.93% of the stock.
MetLife, Inc. is a provider of life insurance, annuities, employee benefits and asset management. The company has a market cap of $60.33 billion. The Company’s divisions include Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America (collectively, the Americas); Asia, and Europe, the Middle East and Africa (EMEA). It has a 16.81 P/E ratio. The Company’s Retail segment is organized into two businesses: Life & Other, and Annuities.
According to Zacks Investment Research, “Metlife Inc. is a leading provider of insurance and financial services to a broad spectrum of individual and institutional customers. The company currently provides individual insurance, annuities and investment products. The company also provides group insurance and retirement and savings products and services to corporations and other institutions. The company believes that their unparalleled franchises and brand names uniquely position them to be the preeminent provider of insurance and financial services in the U.S.”
MetLife, Inc. (MetLife), incorporated on August 10, 1999, is a well-known provider of life insurance, annuities, employee benefits and asset management. The Company’s divisions include Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America (collectively, the Americas); Asia, and Europe, the Middle East and Africa (EMEA). In addition, MetLife’s Corporate & Other contains the surplus portfolios for the enterprise, the portfolios used to fund the capital needs of the Company and various reinsurance agreements. In the United States, the Company provides a range of insurance and financial services products, including life, dental, disability, property and casualty, guaranteed interest, stable value and annuities, through both proprietary and independent retail distribution channels, as well as at the workplace. Outside the United States, the Company provides life, medical, dental, credit and other accident and health insurance, as well as annuities, endowment and retirement and savings products to both individuals and groups.
Another recent and important Metlife Inc (NYSE:MET) news was published by Investorplace.com which published an article titled: “Metlife Inc (MET) Is Starting Its Run” on November 17, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.